People often take aspirin to reduce their risk ofĀ heart attack. But a new study from the U.K. says it could also dramatically cut down the number of cancer cases andĀ cancer deaths.

The research found daily aspirin use amongĀ 50- to 65-year-olds in the U.K. overĀ the course of 10 yearsĀ could reduce deaths from stomach cancer by 35 percent, colorectal cancer by 40 percent and esophageal cancer by 50 percent.

"This 2,000-year-old drug has benefitsĀ today that we need to be paying attention to."

But, asĀ Newser's headline shows, it's not all good news. There's also the risk ofĀ stomach and brain bleeding if you take too much aspirin, and in some cases this can be deadly.

The study, published in theĀ Annals of Oncology, even points out the biggest risks tied to aspirin use areĀ internal bleeding and even strokes. But the scientists say the benefits outweigh the risks.

"In terms of things you can do to prevent cancer, it's clear that the most important thing to do is to avoid smoking ... After that, this is probably the second most important that anyone can do to prevent cancer."Ā (ViaĀ BBC)

AĀ ForbesĀ writerĀ callsĀ the findingsĀ "encouraging."

AndĀ The GuardianĀ calls it theĀ "biggest study yet."Ā The study suggestsĀ about 130,000 lives in BritainĀ could be saved if more people took aspirin. Still, one of the study's scientists says:Ā "[It]Ā should not be seen as a reason for not improving your lifestyle."Ā 

Scientists say they'll still need to do more research to figure out what the ideal dosage is and the number of years people should take it daily.

About the Author

Keep Reading

Sure it's only mid-July, but Escape the Netherworld is hosting five themed escape rooms, including one called Haunted that challenges players to defeat the Night Hag. (Courtesy of Escape the Netherworld)

Credit: Courtesy of Escape the Netherworld

Featured

ā€œOur members cannot be bought off,ā€ General President Sean O’Brien said in a social media statement, calling UPS' offers ā€œillegal and haphazard.ā€ (Hyosub Shin/AJC 2023)

Credit: Hyosub Shin/AJC